"Epitope Mapping" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Methods used for studying the interactions of antibodies with specific regions of protein antigens. Important applications of epitope mapping are found within the area of immunochemistry.
| Descriptor ID |
D018604
|
| MeSH Number(s) |
E05.478.274 E05.601.690.300
|
| Concept/Terms |
Epitope Mapping- Epitope Mapping
- Epitope Mappings
- Mapping, Epitope
- Mappings, Epitope
|
Below are MeSH descriptors whose meaning is more general than "Epitope Mapping".
Below are MeSH descriptors whose meaning is more specific than "Epitope Mapping".
This graph shows the total number of publications written about "Epitope Mapping" by people in this website by year, and whether "Epitope Mapping" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 2 | 2 |
| 1998 | 0 | 2 | 2 |
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 2 | 2 |
| 2003 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
| 2010 | 0 | 2 | 2 |
| 2011 | 0 | 3 | 3 |
| 2012 | 0 | 1 | 1 |
| 2013 | 1 | 3 | 4 |
| 2014 | 1 | 2 | 3 |
| 2015 | 1 | 2 | 3 |
| 2016 | 0 | 5 | 5 |
| 2017 | 1 | 4 | 5 |
| 2018 | 0 | 5 | 5 |
| 2020 | 0 | 3 | 3 |
| 2021 | 0 | 5 | 5 |
| 2022 | 0 | 1 | 1 |
| 2025 | 2 | 0 | 2 |
| 2026 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Epitope Mapping" by people in Profiles.
-
Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice. Nature. 2016 12 15; 540(7633):443-447.
-
Inhibition of cell adhesion by a cadherin-11 antibody thwarts bone metastasis. Mol Cancer Res. 2013 Nov; 11(11):1401-11.
-
Generation of multi-leukemia antigen-specific T cells to enhance the graft-versus-leukemia effect after allogeneic stem cell transplant. Leukemia. 2013 Jul; 27(7):1538-47.
-
Antibody and T cell recognition of the light chain of botulinum neurotoxin A in two high-responder mouse strains. Immunobiology. 2012 Jan; 217(1):1-7.
-
Molecular immune recognition of botulinum neurotoxin B. The light chain regions that bind human blocking antibodies from toxin-treated cervical dystonia patients. Antigenic structure of the entire BoNT/B molecule. Immunobiology. 2012 Jan; 217(1):17-27.
-
Regions of botulinum neurotoxin A light chain recognized by human anti-toxin antibodies from cervical dystonia patients immunoresistant to toxin treatment. The antigenic structure of the active toxin recognized by human antibodies. Immunobiology. 2011 Jul; 216(7):782-92.
-
Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2. J Virol. 2010 Sep; 84(18):9227-39.
-
Analysis of T cell receptor beta chains that combine with dominant conserved TRAV5D-4*04 anti-insulin B:9-23 alpha chains. J Autoimmun. 2009 Aug; 33(1):42-9.
-
Mapping of the CXCR4 binding site within variable region 3 of the feline immunodeficiency virus surface glycoprotein. J Virol. 2008 Sep; 82(18):9134-42.
-
Immune recognition of botulinum neurotoxin B: antibody-binding regions on the heavy chain of the toxin. Mol Immunol. 2008 Feb; 45(4):910-24.